Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Duvaline ER 250 Tablet

Prescription Icon
Prescription Required

Marketer

Laclin Pharma Pvt Ltd

Salt Composition

Divalproex (250mg)

Overview Duvaline ER 250 Tablet

Epileptic seizures and migraines are effectively managed with the extended-release formulation of Duvaline 250mg tablets. This medication can also be prescribed for bipolar disorder, either as a sole treatment or alongside other therapies. Dosage and frequency are determined by your physician to optimize symptom control. Administer at the same time daily, with or without food, for maximum efficacy; therapeutic effects typically appear within a fortnight. Continuous use, as directed, is crucial; missed doses or abrupt cessation can exacerbate your condition and potentially trigger seizures. Gradual discontinuation is always necessary. Common side effects, usually mild, include dizziness, nausea, vomiting, headache, blurred vision, fatigue, unsteady gait, bruising, and hypothermia. While generally manageable, persistent or bothersome effects should prompt consultation with your doctor. Report any skin rash or redness immediately. Prolonged use may lower bone density (osteoporosis), raising fracture risk. Suicidal ideation or behavioral changes are rare but warrant immediate medical attention. Prior to commencing treatment, disclose any history of heart, liver, or kidney disease, urinary difficulties, depression, or suicidal tendencies. Inform your physician of all concurrent medications to prevent adverse drug interactions. Pregnant individuals should consult their doctor before initiating or discontinuing this medication. Alcohol consumption should be avoided due to potential exacerbation of side effects and increased seizure risk. Regular blood tests may be required to monitor therapeutic levels, both before and during treatment.

Primary Ingredients of Duvaline ER 250 Tablet

No information provided. Please provide the text you wish to be rephrased.

Uses of Duvaline ER 250 Tablet

Managing epileptic seizures and bipolar disorder; migraine prevention.

Major Benefits of Duvaline ER 250 Tablet:

Administer Duvaline ER 250 Tablet precisely as directed by your physician, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing. Consumption with or without food is acceptable; however, consistent daily timing is recommended.

Common Side effects of Duvaline ER 250 Tablet:

  • Decreased body temperature
  • Dizziness
  • Sleepiness
  • Tremors
  • Paresthesia (tingling or pricking sensation)
  • Anemia (low number of red blood cells)
  • Decreased sodium level in blood
  • Liver injury
  • Gastrointestinal disturbance
  • Hypersensitivity
  • Deafness
  • Urinary incontinence
  • Increase in body weight
  • Pain during periods

How to use Duvaline ER 250 Tablet:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Duvaline ER 250 Tablet whole; avoid crushing, chewing, or breaking it. While it can be taken with or without food, consistent timing is recommended for optimal results.

How Duvaline ER 250 Tablet works:

Epileptic seizures are managed by the anticonvulsant Duvaline ER 250 mg tablets, which reduce hyperactive neuronal firing in the brain.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of Duvaline ER 250 tablets and alcohol may result in increased sleepiness.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Duvaline 250 mg tablets pose a confirmed risk to a developing fetus and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Extended-release Duvaline 250 mg tablets pose minimal breastfeeding risk. Research in humans indicates negligible transfer to breast milk, posing no apparent threat to the infant.

DrivingDrivingUNSAFE

Driving ability may be impaired by side effects associated with Duvaline ER 250 Tablet.

KidneyKidneySAFE IF PRESCRIBED

Extended-release Duvaline 250 mg tablets are considered safe for use in individuals with impaired renal function. No alteration of the Duvaline ER 250 mg tablet dosage is necessary.

LiverLiverUNSAFE

Patients with liver conditions should not take Duvaline ER 250 Tablets; this medication is likely unsafe for them. Medical advice is recommended.

What if you forget to take Duvaline ER 250 Tablet :

Should you forget a Duvaline ER 250 Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Duvaline ER 250 Tablet

LabelValue
Chemical Classification Derivatives of Aliphatic Carboxylic Acids
Developing Habits No.
Treatment Category Neuroscience of the Central Nervous System
Actions Antiepileptic drugs targeting sodium channels

FAQs on Duvaline ER 250 Tablet

Always consult your doctor before discontinuing Duvaline ER 250 Tablet. Withdrawal should be gradual and supervised to minimize potential side effects such as symptom recurrence, irritability, anxiety, dizziness, and tremors.
Duvaline ER 250 Tablets can act as a mood stabilizer in some cases, particularly for patients experiencing rapid mood swings. The medication achieves this by reducing excessive brain activity associated with these mood changes.
Duvaline ER 250 Tablets may cause weight gain, potentially due to increased appetite. Manage your diet and exercise to minimize this risk. Consult your doctor if weight gain is a concern.
Duvaline ER 250 Tablets may cause drowsiness. Refrain from driving or activities requiring alertness until you understand its effects on you.
Hair loss is a possible, though typically temporary and dose-dependent, side effect of Duvaline ER 250 Tablets. Consult your physician if this side effect concerns you or continues.
Duvaline ER 250 Tablets can cause liver damage, particularly within the first six months of treatment. Symptoms of this may include nausea, vomiting, appetite loss, stomach pain, dark urine, facial swelling, and jaundice (yellowing of skin or eyes). Liver function tests are crucial before starting and periodically during the initial six months, especially for at-risk individuals or those with pre-existing liver conditions.
Refrain from drinking alcohol during your Duvaline ER 250 Tablet treatment. Combining alcohol with this medication may increase drowsiness, dizziness, or lightheadedness.
Before starting Duvaline ER 250 Tablet treatment, your doctor may order blood tests. These may include a complete blood count (with platelet count), bleeding time, and coagulation studies to help prevent bleeding or bruising. Liver function tests are also recommended before and, particularly for high-risk patients or those with a history of liver disease, during the first six months of treatment.
Severe abdominal pain, nausea, and vomiting may indicate pancreatitis. Seek immediate medical attention if you experience these symptoms. Your doctor may order a serum amylase test; a positive result necessitates immediate medication cessation.
Duvaline ER 250 Tablet overdose can lead to headaches, blurred vision (from constricted pupils), reduced reflexes, confusion, and drowsiness. Further symptoms may include muscle weakness, seizures, unconsciousness, altered behavior, and respiratory problems like rapid breathing, shortness of breath, or chest pain. Seek immediate medical help if an overdose occurs.
Duvaline ER 250 Tablet
65
MRP 75
13% off